 OptimizeRx Corporation NASDAQ: OPRX prices its previously announced underwritten public offering of 1.325 million common shares, at 49.50 per share, raising 65.6 million in gross proceeds. Underwriters have an option to purchase up to an additional 198,750 shares. 